Dabomb Protein Biotech (ROCO:6578) Cyclically Adjusted Book per Share: NT$22.68 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6578 Dabomb Protein Biotech Corp ROCO:6578
59 GF Score
Price NT$16.05
GF Value NT$14.49
Valuation Modestly Overvalued
! 1 Warning Sign
View Full Analysis

What is Dabomb Protein Biotech Cyclically Adjusted Book per Share?

Dabomb Protein Biotech ROCO:6578 -1.53% 59 Cyclically Adjusted Book per Share is NT$22.68 as of Dec. 2025. GuruFocus rates ROCO:6578 with a GF Score™ of 59/100 and a GF Value™ of NT$14.49 (Modestly Overvalued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Dabomb Protein Biotech's adjusted book value per share for the three months ended in Dec. 2025 was NT$13.751. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is NT$22.68 for the trailing ten years ended in Dec. 2025.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-15), Dabomb Protein Biotech's current stock price is NT$16.05. Dabomb Protein Biotech's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2025 was NT$22.68. Dabomb Protein Biotech's Cyclically Adjusted PB Ratio of today is 0.71.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Dabomb Protein Biotech was 0.92. The lowest was 0.67. And the median was 0.83.


Dabomb Protein Biotech  (ROCO:6578) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Dabomb Protein Biotech's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=16.05/22.68
=0.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Dabomb Protein Biotech was 0.92. The lowest was 0.67. And the median was 0.83.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Dabomb Protein Biotech Cyclically Adjusted Book per Share Related Terms


Dabomb Protein Biotech Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Dabomb Protein Biotech's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dabomb Protein Biotech Cyclically Adjusted Book per Share Chart

Dabomb Protein Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 22.68

Dabomb Protein Biotech Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 22.97 22.68

ROCO:6578 vs KHC, GIS: Cyclically Adjusted Book per Share Comparison

For the Packaged Foods subindustry, Dabomb Protein Biotech's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dabomb Protein Biotech Cyclically Adjusted PB Ratio vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Dabomb Protein Biotech's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Dabomb Protein Biotech's Cyclically Adjusted PB Ratio falls into.


ROCO:6578
59GF Score
Dabomb Protein Biotech Corp ROCO:6578
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dabomb Protein Biotech Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Dabomb Protein Biotech's adjusted Book Value per Share data for the three months ended in Dec. 2025 was:

Adj_Book= Book Value per Share /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=13.751/324.0540*324.0540
=13.751

Current CPI (Dec. 2025) = 324.0540.

Dabomb Protein Biotech Quarterly Data

Book Value per Share CPI Adj_Book
201412 19.180 234.812 26.469
201512 20.680 236.525 28.333
201606 20.894 241.018 28.092
201612 21.626 241.432 29.027
201703 0.000 243.801 0.000
201706 20.784 244.955 27.495
201709 0.000 246.819 0.000
201712 21.620 246.524 28.419
201803 21.978 249.554 28.539
201806 21.669 251.989 27.866
201809 21.364 252.439 27.425
201812 21.654 251.233 27.931
201903 22.153 254.202 28.240
201906 21.698 256.143 27.451
201909 21.538 256.759 27.183
201912 21.199 256.974 26.733
202003 20.963 258.115 26.318
202006 20.574 257.797 25.862
202009 20.464 260.280 25.478
202012 20.722 260.474 25.780
202103 19.916 264.877 24.365
202106 19.654 271.696 23.441
202109 19.122 274.310 22.590
202112 20.381 278.802 23.689
202203 19.348 287.504 21.808
202206 18.980 296.311 20.757
202209 18.792 296.808 20.517
202212 18.404 296.797 20.094
202303 18.069 301.836 19.399
202306 15.697 305.109 16.672
202309 15.326 307.789 16.136
202312 16.045 306.746 16.950
202403 16.118 312.332 16.723
202406 15.489 314.175 15.976
202409 15.241 315.301 15.664
202412 16.023 315.605 16.452
202503 15.228 319.799 15.431
202506 14.330 322.561 14.396
202509 14.270 324.800 14.237
202512 13.751 324.054 13.751

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of NT$22.68 mean?
Dabomb Protein Biotech (ROCO:6578) has a Cyclically Adjusted Book per Share of NT$22.68 as of Dec. 2025. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Dabomb Protein Biotech and its competitors.
Is Dabomb Protein Biotech's Cyclically Adjusted Book per Share too high?
Dabomb Protein Biotech's current Cyclically Adjusted Book per Share is NT$22.68. Overall, Dabomb Protein Biotech has a GF Score™ of 59/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Dabomb Protein Biotech's Cyclically Adjusted Book per Share compare to KHC and GIS?
Dabomb Protein Biotech's Cyclically Adjusted Book per Share of NT$22.68 can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Consumer Packaged Goods company?
A good Cyclically Adjusted Book per Share depends on the Consumer Packaged Goods industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Dabomb Protein Biotech and its competitors. Dabomb Protein Biotech's current Cyclically Adjusted Book per Share is NT$22.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dabomb Protein Biotech stock overvalued right now?
Based on GuruFocus' analysis, Dabomb Protein Biotech (ROCO:6578) is currently considered Modestly Overvalued. The stock's GF Value™ is NT$14.49, compared to a current price of NT$16.05 — trading 10.8% above its estimated fair value. The current Cyclically Adjusted Book per Share is NT$22.68. Dabomb Protein Biotech's overall GF Score™ is 59/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Dabomb Protein Biotech (ROCO:6578), the current Cyclically Adjusted Book per Share is NT$22.68 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dabomb Protein Biotech (ROCO:6578) Overvalued in 2026?

Based on GuruFocus' analysis, Dabomb Protein Biotech stock appears to be overvalued. The current stock price of NT$16.05 is trading 10.8% above its estimated GF Value™ of NT$14.49. GuruFocus considers Dabomb Protein Biotech to be Modestly Overvalued.

Key valuation signals for ROCO:6578:

  • Cyclically Adjusted Book per Share: NT$22.68
  • GF Value™: NT$14.49 vs. price of NT$16.05 (10.8% above fair value)
  • GF Score™: 59/100 with 1 warning sign

No single metric tells the full story. See the ROCO:6578 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Dabomb Protein Biotech Business Description

Address No. 52, Industrial 3rd Road, Annan District, Tainan, TWN, 709
Dabomb Protein Biotech Corp is engaged in the manufacture, wholesale, and sale of hydrolyzed soy protein. The products of the company include Plant protein, Antibiotics alternatives, Pet care, Core technology, and CDMO(ODM/OEM). The company operates in a single segment engaged in the manufacture, wholesale and sales of hydrolysed soy protein. Geographically it operates in Malaysia, Taiwan, USA, Vietnam, and Others with majority of the revenue deriving from Vietnam.
59GF Score

Get the complete analysis for ROCO:6578

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$16.05
Price
NT$14.49
GF Value